Centre for Research in Public Health and Community Care (CRIPACC), University of Hertfordshire, Hatfield; evidence & evaluation lead, patient safety, Medical Directorate, NHS Improvement, London.
Hertfordshire Business School, University of Hertfordshire, de Havilland Campus, Hatfield.
Br J Gen Pract. 2018 Oct;68(675):e711-e717. doi: 10.3399/bjgp18X699101.
Polypharmacy is common among older adults, with increasing numbers also using prescription drugs with herbal medicinal products (HMPs) and dietary supplements. There is no reliable evidence from the UK on concurrent use of HMPs and dietary supplements with prescription drugs in older adults.
To establish prevalence of concurrent prescription drugs, HMPs, and dietary supplements among UK community-dwelling older adults and identify potential interactions.
Cross-sectional survey of older adults registered at two general practices in South East England.
A questionnaire asking about prescription medications, HMPs, and sociodemographic information was posted to 400 older adults aged ≥65 years, identified as taking ≥1 prescription drug.
In total 155 questionnaires were returned (response rate = 38.8%) and the prevalence of concurrent HMPs and dietary supplements with prescriptions was 33.6%. Females were more likely than males to be concurrent users (43.4% versus 22.5%; = 0.009). The number of HMPs and dietary supplements ranged from 1 to 8, (mean = 3, median = 1; standard deviation = 1.65). The majority of concurrent users (78.0%) used dietary supplements with prescription drugs. The most commonly used dietary supplements were cod liver oil, glucosamine, multivitamins, and vitamin D. Others (20.0%) used only HMPs with prescription drugs. Common HMPs were evening primrose oil, valerian, and Nytol Herbal (a combination of hops, gentian, and passion flower). Sixteen participants (32.6%) were at risk of potential adverse drug interactions.
GPs should routinely ask questions regarding herbal and supplement use, to identify and manage older adults at potential risk of adverse drug interactions.
老年人普遍存在多种药物治疗的情况,同时使用处方药物与草药药物(HMPs)和膳食补充剂的人数也在增加。在英国,没有关于老年人同时使用 HMPs 和膳食补充剂与处方药物的可靠证据。
确定英国社区居住的老年人同时使用处方药物、HMPs 和膳食补充剂的流行情况,并确定潜在的相互作用。
在英格兰东南部的两家普通诊所对老年人进行横断面调查。
向 400 名年龄≥65 岁、服用≥1 种处方药物的老年人邮寄了一份包含处方药物、HMPs 和社会人口统计学信息的问卷。
共收回 155 份问卷(应答率=38.8%),同时使用 HMPs 和膳食补充剂与处方药物的比例为 33.6%。女性同时使用者的比例高于男性(43.4%比 22.5%;=0.009)。HMPs 和膳食补充剂的数量从 1 到 8 不等,(平均值=3,中位数=1;标准差=1.65)。大多数同时使用者(78.0%)将膳食补充剂与处方药物一起使用。最常用的膳食补充剂是鱼肝油、氨基葡萄糖、多种维生素和维生素 D。其他(20.0%)仅使用 HMPs 与处方药物一起使用。常见的 HMPs 是月见草油、缬草根和 Nytol 草药(由啤酒花、龙胆和西番莲组成的混合物)。有 16 名参与者(32.6%)存在潜在药物不良反应风险。
全科医生应常规询问有关草药和补充剂使用的问题,以识别和管理可能存在药物不良反应风险的老年人。